CURE’s vulvar cancer page features the latest cancer news and updates on vulvar cancer Through articles, videos, podcasts, and more, CURE brings readers the insights of experts, cancer survivors, patients, and advocates to ensure everyone is up to date in vulvar cancer.
April 10th 2020
A patient turned advocate underscores the importance of education, especially for those facing a rare cancer.
April 4th 2019
We've got a sneak peek at what’s inside CURE®'s Women’s Cancers issue.
January 25th 2019
Nearly 90 percent of women experienced sexual dysfunction; however, providers were not openly communicating about this side effect, according to survey results.
October 6th 2018
The Food and Drug Administration (FDA) approved an expanded age indication for GARDASIL 9 (Human Papillomavirus 9-valent Vaccine, Recombinant), according to Merck, the manufacturer of the HPV vaccine.
June 13th 2018
The application is seeking approval for GARDASIL 9 to be used in women and men aged 27 to 45 years for the prevention of certain cancers and diseases caused by the nine human papillomavirus (HPV) types covered by the vaccine.
March 21st 2018
Women with vulvar cancer who test positive for human papillomavirus (HPV) may have improved survival compared with HPV-negative patients, according to the results of a new study.
May 18th 2017
Despite impressive efficacy for the human papillomavirus (HPV) vaccine reducing the prevalence of high-risk oral HPV infections by 88 percent, many young adults still are not getting the vaccine – sparking concern in the health community.
April 27th 2017
Treatment changes for the rare illness include less invasive surgery.
April 17th 2015
A new study has shown that vaccinating adolescent boys may be cost-effective for preventing oropharyngeal cancer, a disease that's projected to become the most common HPV-related cancer by 2020.
February 20th 2015
States with the highest incidence of, and mortality from, cervical cancer also have the lowest uptake of the human papillomavirus (HPV) vaccine by adolescent girls, researchers found in a recent study.
January 23rd 2015
There are some things known to increase the risk of gynecologic cancers. Bottom line, being a woman puts you at risk.
November 25th 2014
NORD was founded in 1983 by parents of children with rare diseases. Over the past 30 years, it has become a powerful advocacy voice for all patients with rare diseases, including cancer.